Balchem Corp (BCPC) is a publicly traded company in the Basic Materials — Chemicals - Specialty industry listed on NASDAQ. This overview shows the latest price, key valuation ratios, profitability metrics and financial-health indicators used by fundamental investors.
Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry.
Is Balchem Corp stock overvalued or undervalued in 2026?
Balchem Corp (BCPC) trades at 33.5× earnings (P/E), above the median of the 156 materials companies over $2bn in Kaplio's universe. At the decade median (42.1×) $214 (+26 %); at its sector median (18.8×) $96 (-44 %).
Kaplio overview: Balchem Corp
Market cap $5B · 52 weeks $147 – $183 (7 % below the high) · P/E 33.5× · 2027 expected P/E 30.1× · Dividend 0.56 % · 11 years rising · Next earnings February 19, 2027 · expected EPS $1.38 · Closing price, Oct 30 · accounts published Oct 23.
- Valuation: P/E 33.5× (cheap).
- Business: ROIC 12 % (fair).
- Balance sheet: Net debt/EBITDA 0.5× (solid).
- Earnings: 4 of 8 (uneven).
What would it be worth at its usual multiples?
At the decade median (42.1×) $214 (+26 %); at its sector median (18.8×) $96 (-44 %). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
What matters in materials: 6 of 8 pass
- FCF yield 3.2 %, fails.
- P/B across cycles 4.1×, fails.
- Gross margin 35.7 %, passes.
- Net debt / EBITDA (trough) 0.5×, passes.
- Dividend coverage 6.1×, passes.
- Capex / D&A 1.0×, passes.
- Altman Z-Score 8.7, passes.
- Cycle-adjusted EV/EBITDA 20.0×, passes.
Against its peers (reference peers) — Balchem Corp: P/E 33.5×; EV/EBITDA 20.0×; ROIC 11.9 %; $5.4B. Sensient Technologies Corporation (P/E 31.7×; EV/EBITDA 21.0×; ROIC 8.6 %; $5.0B), Avient Corporation (P/E 23.2×; EV/EBITDA 10.7×; ROIC 4.7 %; $3.9B), Eastman Chemical Company (P/E 17.3×; EV/EBITDA 9.7×; ROIC 5.1 %; $7.6B).
Expensive or cheap against its last ten years?
P/E at each close: today 33.5× · median 42.1× · minimum 27.0× · maximum 64.1× · cheap below 39.4× · expensive above 47.3×. It has been cheaper than today only 9% of the time over its last ten years.
Dividend
solid · Yield 0.56 % ($0.87 per share in 2025) · Years raising it ≥ 11 · 5-year growth +11 % a year · Free cash flow coverage 6.1× · With $1,000 invested today you'd collect $5.60 a year ($0.47 a month).
Profitability
| Return on Equity | 13.21% |
| Return on Invested Capital | 11.92% |
| Return on Assets | 10.03% |
| Gross Margin | 36.46% |
| Operating Margin | 21.40% |
| Net Margin | 15.41% |
Financial Health
| Debt / Equity | 0.11 |
| Current Ratio | 2.47 |
| Piotroski F-Score | 8 |
| Altman Z-Score | 8.75 |
Price Performance
| 1 month | +4.10% |
| 3 months | +1.69% |
| Year-to-date | +11.11% |
| 1 year | +11.09% |
| 3 years | +46.02% |
| 5 years | +12.11% |
| 10 years | +130.58% |
Dividend History
Paid in the last 12 months: $0.9600 per share in 1 payments.
| Date | Amount |
|---|---|
| 2026-12-31 | $0.3984 |
| 2025-12-23 | $0.9600 |
| 2024-12-26 | $0.8700 |
| 2023-12-26 | $0.7900 |
| 2022-12-23 | $0.7100 |
| 2021-12-27 | $0.6400 |
| 2020-12-24 | $0.5800 |
| 2019-12-27 | $0.5200 |
| 2018-12-24 | $0.4700 |
| 2017-12-26 | $0.4200 |
Amounts adjusted for stock splits.
Related companies: HWKN · IOSP · IFF · EMN · INGR · SXT · AVNT · FUL
Explore sector: Basic Materials · Chemicals - Specialty
More sections of BCPC: Financials · Valuation · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks